Brief: Spago Nanomedical Q2 Pre-tax Loss SEK 7 Mln
Aug 20 (Reuters) - Spago Nanomedical AB (publ) SPAGO.ST: Q2 NET SALES FOR QUARTER AMOUNTED TO 81 KSEK Q2 PRE-TAX RESULT FOR QUARTER WAS LOSS 6,964 KSEK Source text: ID:nMFN4NzH62 Further company coverage: SPAGO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose